Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mammographic breast density and race.
del Carmen MG, Halpern EF, Kopans DB, Moy B, Moore RH, Goss PE, Hughes KS. del Carmen MG, et al. Among authors: moy b. AJR Am J Roentgenol. 2007 Apr;188(4):1147-50. doi: 10.2214/AJR.06.0619. AJR Am J Roentgenol. 2007. PMID: 17377060
TEACH: Tykerb evaluation after chemotherapy.
Moy B, Goss PE. Moy B, et al. Clin Breast Cancer. 2007 Feb;7(6):489-92. doi: 10.3816/CBC.2007.n.007. Clin Breast Cancer. 2007. PMID: 17386127 No abstract available.
Lapatinib.
Moy B, Kirkpatrick P, Kar S, Goss P. Moy B, et al. Nat Rev Drug Discov. 2007 Jun;6(6):431-2. doi: 10.1038/nrd2332. Nat Rev Drug Discov. 2007. PMID: 17633789 No abstract available.
Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial.
Goss PE, Smith IE, O'Shaughnessy J, Ejlertsen B, Kaufmann M, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Chavarri-Guerra Y, Aktan G, Rappold E, Williams LS, Finkelstein DM; TEACH investigators. Goss PE, et al. Among authors: moy b. Lancet Oncol. 2013 Jan;14(1):88-96. doi: 10.1016/S1470-2045(12)70508-9. Epub 2012 Dec 10. Lancet Oncol. 2013. PMID: 23234763 Clinical Trial.
A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases.
Lin NU, Freedman RA, Ramakrishna N, Younger J, Storniolo AM, Bellon JR, Come SE, Gelman RS, Harris GJ, Henderson MA, Macdonald SM, Mahadevan A, Eisenberg E, Ligibel JA, Mayer EL, Moy B, Eichler AF, Winer EP. Lin NU, et al. Among authors: moy b. Breast Cancer Res Treat. 2013 Nov;142(2):405-14. doi: 10.1007/s10549-013-2754-0. Epub 2013 Nov 7. Breast Cancer Res Treat. 2013. PMID: 24197661 Clinical Trial.
211 results